Symbol="QLGN"
AssetType="Common Stock"
Name="Qualigen Therapeutics Inc"
Description="Qualigen, Inc., a biotechnology company, develops new therapeutic products for the treatment of cancer and infectious diseases. The company is headquartered in Carlsbad, California."
CIK="1460702"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1880 CENTURY PARK EAST, SUITE 1000, LOS ANGELES, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4830200"
EBITDA="-16445027"
PERatio="None"
PEGRatio="None"
BookValue="0.964"
DividendPerShare="0"
DividendYield="0"
EPS="-4.25"
RevenuePerShareTTM="1.398"
ProfitMargin="0"
OperatingMarginTTM="-2.833"
ReturnOnAssetsTTM="-0.6"
ReturnOnEquityTTM="-2.112"
RevenueTTM="5868700"
GrossProfitTTM="680800"
DilutedEPSTTM="-4.25"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.226"
AnalystTargetPrice="22.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.178"
PriceToBookRatio="0.492"
EVToRevenue="0.368"
EVToEBITDA="-0.105"
Beta="0.0588"
num_52WeekHigh="5.03"
num_52WeekLow="0.83"
num_50DayMovingAverage="0.978"
num_200DayMovingAverage="1.429"
SharesOutstanding="5052500"
DividendDate="2020-05-26"
ExDividendDate="None"
symbol="QLGN"
open="0.95"
high="1.00"
low="0.95"
price="1.00"
volume="27449.00"
latest_trading_day="2023-07-13"
previous_close="0.95"
change="0.05"
change_percent="4.8305%"
aroon_positive_momentum_days="21"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="21"
Volume_recent_avg="120805"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.94"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="21"
Aroon_momentum_negative="79"
image_negative_thumbnail_id_1="1153"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0186.jpeg"
image_negative_thumbnail_id_2="1146"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0179.jpeg"
image_neutral_thumbnail_id_1="565"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_neutral_thumbnail_id_2="525"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_positive_thumbnail_id_1="645"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0063.jpeg"
image_positive_thumbnail_id_2="618"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
